been available for 40 years (3, 4, 31) , and the method of standardization for study of ligandprotein interactions has been described (39) and used in non-antibiotic-containing systems (18) . However, the ultracentrifuge has only occasionally been used, and its use has never been standardized for the study of antibiotic-protein binding (8, 17, 32, 37, 38) .
The present study compares and evaluates these three newer methods for determining protein binding of pen G: rate of dialysis (11, 42) , cross-linked dextran exclusion (35) , and ultracentrifugation (39) .
MATERIALS AND METHODS
Rate of dialysis. The method used was a modification of that reported by Colowick and Womack (11, 42) . Studies of quantitative binding and immediate reversibility were performed in a 37°C water bath using a Bio-Rad minibeaker (Bio-Fiber 50 Minibeaker, Bio-Rad Laboratories, Richmond, Calif.).
This minibeaker consisted of a chamber into which a radioactive test solution can be added, and contained numerous small Visking tubes (Visking Co., Chicago, Ill.) passing through the chamber, through which a protein-free solution was infused. An ultrafiltrate of human serum at pH 7.3 to 7.5 was passed through the tubing system at a rate of 3 ml/min as the protein-free side ofthe membrane into which the radioactive pen G (benzyl[14Clpenicillin, potassium, 43.5 ,uCi/mg; Amersham/Searle Corp.) diffused from the sample chamber. Fractions were collected on a drop counter fraction collector in 0.6-ml volumes. Radioactivity was determined on a Beckman LS-100C liquid scintillation counter (Beckman Instruments, Inc., Palo Alto, Calif.), using Aquasol (New England Nuclear, Boston, Mass.) as the scintillation solution.
The control sample consisted of 6 ml of an ultrafiltrate of human serum containing 60 U of pen G and 0.5 ,Ci of '4C-pen G. This sample was introduced 993 ANTIMICROB. AGENTs CHEMOTHER.
into the chamber, which contained a magnetic stir bar to insure mixing, and eight fractions were collected for radioactive determinations from the effluent passing through the fiber system. During collection of the eighth fraction, 2 ml of ultrafiltrate containing 800,000 U of pen G was added to the sample chamber, and an additional nine effluent fractions were collected.
This procedure was repeated, using serum instead of ultrafiltrate in the sample chamber. Serum was mixed with pen G and 14C-pen G and either immediately introduced into the minibeaker chamber or incubated at 37°C for 1 h before being placed in the chamber. Eight fractions of the ultrafiltrate passing through the fibers were collected, and then an additional 2 ml of serum containing 800,000 U of pen G was added to the chamber to release proteinbound 14C-pen G. The radioactivity in each collected fraction was then measured.
Additionally, studies were performed to evaluate any delayed release of 14C-pen G bound to protein.
Unlabeled pen G was added to serum containing 10 U of pen G and 0.1 ,uCi of 14C-pen G per ml to bring the final concentration of pen G to 100,000 U/ml. This mixture was incubated for 1, 5, 15, and 30 min at 370C, and 8 ml was then pipetted into a minibeaker chamber. Eight effluent fractions were collected, and the radioactivity in each fraction was compared with that obtained from an ultrafiltrate control sample containing 100,000 U ofpen G and 0.1 ,uCi of "4C-pen G per ml.
Cross-linked dextran exclusion. Determination of pen G binding to protein was performed by the method described by Pearlman and Crepy (35) . When cross-linked dextran (Sephadex, Pharmacia Fine Chemicals, Inc., Piscataway, N.J.) is added to a solution containing known amounts of protein and ligand (1), the protein will be concentrated in the external phase (Ve) of the Sephadex, and this external phase will also contain both free (F) and proteinbound (B) ligand. Only free ligand will be allowed into the internal (V,) compartment of the Sephadex. After equilibration of Sephadex with the starting solution, the concentration of ligand in the external phase ([t]) can be measured, and the concentration of free ligand ([F] ) can be calculated from:
[F] = (1 -[t] Ve)/Vi (1) Once the concentration of free drug is known, the protein binding ofthe ligand is easily determined. The internal volume of the Sephadex G-25 (fine) was determined by placing 300 mg of Sephadex in 1.5 ml of human serum ultrafiltrate containing 2.5 g of albumin per 100 ml. After 3-li swelling time in a 37°C shaking water bath, the equilibration of Sephadex was complete and 0. (2) Internal volume of 300 mg of Sephadex in this system is then: V, = 1.5 ml -Ve (3) Serum protein-binding determinations were performed by adding 300 mg of Sephadex G-25 (fine) to small disposable tubes (Falcon 2054 tube, BectonDickinson and Co., Oxnard, Calif.) containing a mixture of 0.9 ml of pooled human serum, 0.6 ml of human serum ultrafiltrate, 0.03 ,uCi of "4C-pen G, and known quantities of cold (unlabeled) pen G. Determinations were performed at 10, 100, 1,000, 10,000, and 50,000 U of pen G per ml. Control solutions containing pen G in serum ultrafiltrate were also evaluated. The tubes were then placed in a shaking water bath for 3 h at 37°C to swell the Sephadex. After 3 h, 0.2 ml of supernatant was removed from each tube, and radioactivity in this sample was compared with that of the starting solutions. Serum protein binding was calculated from equation 1. Ultracentrifugation. Ultracentrifugation was standardized according to the method of Steinberg and Schachman (39) . Sedimentation velocity experiments (high-speed centrifugation) were compared with sedimentation equilibrium studies (low-speed centrifugation) in order to validate the high-speed method.
Sedimentation equilibrium studies were performed by mixing 80 U of pen G and 0.25 ,uCi of 14C-pen G with 8 ml of human serum ultrafiltrate containing 5.0 g of human serum albumin (Cutter Laboratories, Berkeley, Calif.) per 100 ml in an ultracentrifuge cell (Beckman 335349 polycarbonate ultracentrifuge tube, Beckman Instruments, Inc., Palo Alto, Calif.). Centrifugation was performed for 16 h at 14,000 x g (center of the cell forces) at 3°C on a Beckman L2-65B preparative ultracentrifuge (Beckman Instruments, Inc.), using a type 65 fixed-angle centrifuge rotor (Beckman Instruments, Inc.). Four samples were taken at 1.5-cm intervals throughout the cell and assayed for protein (30) and radioactivity. A control solution containing pen G and "4C-pen G in ultrafiltrate only was also evaluated. Radioactivity was plotted against protein concentration, and the amount of free 14C-pen G was determined by extrapolating to zero protein.
Sedimentation velocity experiments were performed on similar samples with centrifugation for 3 h at 295,000 x g (center of the cell forces) at 3'C on the Beckman L2-65B centrifuge. The top 0.5 ml of sample from each centrifuge cell was removed and assayed for radioactivity. Three hours at 295,000 x g was necessary to achieve a 100-fold increase in protein from the top to the bottom of the centrifuge cell (18) . Preliminary sedimentation velocity studies to compare serum binding at 3'C and 30 to 35'C were performed at a pen G concentration of 10 U/ml. Serum samples containing 10, 100, 1,000, 10,000, and 100,000 U of pen G per ml plus 0.03 ,Ci of 14C-pen G per ml were evaluated by the sedimentation velocity method at 30 to 35'C. The top 0.5 ml from each centrifuge cell was assayed for both radioactive and biological activity. The levels of "free" or unbound pen G determined by both the sedimentation equilibrium and sedimentation velocity methods were compared with levels of pen G in the appropriate starting solution to calculate albumin and serum protein binding. tained from a pool of at least 10 normal fasting volunteers. Serum ultrafiltrate was obtained by passing pooled serum twice through a 90-mm ultrafiltration system (Millipore Corp., Bedford, Mass.) to yield a filtrate containing 0.2 g of protein per 100 ml but no albumin. All sera, filtrates, and other solutions were brought to pH 7.3 to 7.5 with either sodium bicarbonate or carbon dioxide before use. Scintillation counting was performed on a Beckman LS-100C scintillation counter, using Aquasol as a scintillation solution.
Radioactive pen G was determined to be 95 to 97% bioactive drug by paper chromatography and by Sephadex G-10 column chromatography, using a pH 7.0 saline buffer system.
Antibiotic assays were performed in triplicate, using a microbiological disk-plate method with a 24-h incubation at 37°C (29) . Bacillus subtilis ATCC 6633 was used as the test organism, and standard curves were prepared in the same solution as samples to be tested.
RESULTS
Rate of dialysis. Results of radioactivity determined in each fraction collected are corrected for differences in radioactivity in the starting samples, and then results from the quantitative binding and immediate reversibility experiments are normalized to mean activity found in fractions 13 to 15 of the albuminfree control sample and plotted. There were no differences between incubated and unincubated serum samples, indicating that complete binding occurred in seconds or less (Fig. 1) . Also, upon addition of excess nonradioactive pen G there was immediate release of protein-bound 14C-pen G; however, the concentration of free drug only attained 77.2% of that in the nonprotein-containing ultrafiltrate control, suggesting that the initial release was not 100%. The drop in radioactivity of the control solution was due to dilution of radioactive drug upon addition of the 2 ml of unlabeled pen G. Comparison of serum to ultrafiltrate control radioactivity in fractions 6 to 8 showed 51.5% binding of pen G at 10 U/ml (Table 1) .
Results from the delayed-release proteinbinding experiments are normalized to mean activity found in fractions five to seven of the ultrafiltrate control solution and plotted. Binding of 14C-pen G after addition of a concentration of 100,000 U of cold pen G per ml was 9% at 1 min, 5%at 5 min, 5% at 15 min, and 13% at 30 min, with an overall mean of 8%. Therefore, although 22 .8% of pen G was not immediately released from serum protein-binding sites, an additional 14.8% appeared to be released within the first minute after additions of excess cold pen G.
Cross-linked dextran exclusion. The Vi (equation 2) found for Sephadex G-25 (fine) was ' Calculation based on human serum containing 4.0 g of albumin per 100 ml with a molecular weight of 68,000 and potassium pen G with a molecular weight of 374.
b NT, Not tested.
c Results having at least a 1-min incubation of 100,000 U of pen G per ml with '4C-pen G. (26, 36) . Results obtained using the sedimentation velocity method are in good agreement with previous reports (28, 41) , as are the comparable results obtained with both the radioactive and bioassay determinations (27) . This method could easily be extended to tissue-binding studies, and because of the similarity of their structure and molecular weight, this technique should be valid for all the penicillins (16 
